PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer

Overview of attention for article published in Frontiers in oncology, February 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 38,094 followers.

RT @DrImranSheikh: PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer: MCL1 is a me…

04 Feb 2024

Reply Repost Favourite

PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer: MCL1 is a member of the BCL2 family of apoptosis regulators, which play a critical role in promoting cancer survival and…… #oncology https://t.co/g

04 Feb 2024

Reply Repost Favourite

RT @FrontOncology: New research: PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer…

03 Feb 2024

Reply Repost Favourite

RT @FrontOncology: New research: PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer…

03 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.